Crowell represented Marshall Wace on the deal.Marshall Wace, a global alternative investment manager, announced a $41.5 million Series B round of funding of Parse Biosciences. Marshall Wace…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
